Virenix Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Virenix General Information
Description
Developer of antiviral drugs for diseases based in France. The company provides services in synergy with the research for antiviral drugs as well as provides access to a catalog of viral proteins, selling graphics software crystallography, expression, and protein crystallography, and the screening of viral proteins or viruses for the discovery of new drugs.
Contact Information
Website
virenix.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Primary Office
- France
Virenix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Startup |
Virenix Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Vincent L'Hermite | Project Leader |
Virenix Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Incubateur Impulse | Accelerator/Incubator | 000 0000 | 000000 0 |